Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 4,678 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: 6 Week Intervention Clear all

Conditions: Urinary Incontinence, Pelvic Floor Disorders
Interventions: Pericoach® by Analytica, Pelvic Floor Physical Therapy; Device · Other
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 3
States / cities: Monroeville, Pennsylvania • Pittsburgh, Pennsylvania • Wexford, Pennsylvania

Conditions: Type 1 Diabetes (T1D)
Interventions: BREATHE-T1D, HealthEd-T1D; Behavioral
Lead sponsor: Children's National Research Institute; Other
Eligibility: 13 Years to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Aurora, Colorado • Washington D.C., District of Columbia

Conditions: Hypertension
Interventions: Health Literacy-Focused High Blood Pressure Intervention; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Ellicott City, Maryland

Conditions: Gestational Diabetes Mellitus, Type 2 Diabetes Mellitus, Metabolic Syndrome, Impaired Glucose Tolerance, Disorder of Glucose Regulation
Interventions: Metformin XR plus placebo, Metformin XR plus liraglutide; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 153 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Physical Inactivity
Interventions: Episodic future thinking, Positive affect imagery, Action planning, High dose, Recent thinking, Neutral imagery, Low dose; Behavioral
Lead sponsor: Southern Methodist University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 184 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Brain Tumor, Central Nervous System Tumors, Childhood Germ Cell Tumor
Interventions: carboplatin, etoposide, ifosfamide, thiotepa, adjuvant therapy, conventional surgery, neoadjuvant therapy, peripheral blood stem cell transplantation, radiation therapy; Drug · Procedure · Radiation
Lead sponsor: Children's Oncology Group; Network
Eligibility: 3 Years to 24 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 90
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 79 more

Conditions: Generalized Anxiety Disorder
Interventions: Strength Training, Endurance Training; Other
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Child Behavior Disorders
Interventions: PriCARE; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years and older
Enrollment: 199 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Renal Transplant Rejection
Interventions: Sirolimus, Demographic Data, Medical History, and Donor Data, Blood Draws for Control Group, Blood Draws for Experimental Group, Donor Blood Draws, Donor Information, Kidney Biopsy; Drug · Other · Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Myeloid Leukemia
Interventions: Cyclophosphamide, Fludarabine, Clofarabine, Etoposide, Interleukin-2, Natural Killer Cell Infusion, CliniMACS System; Drug · Procedure · Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Fetal Alcohol Spectrum Disorders, Fetal Alcohol Syndrome, Fetal Alcohol Effect
Interventions: General information, Baseline brief intervention, Remote online booster sessions, SMS; Other · Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: Mental Health Disorder
Interventions: Arena Strive, Control Cohort; Device · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Lung Adenocarcinoma, Lung Adenosquamous Carcinoma, Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
Interventions: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Ipilimumab, Magnetic Resonance Imaging, Nivolumab, Positron Emission Tomography, Quality-of-Life Assessment, Radiation Therapy; Procedure · Biological · Other + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 427 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 169
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Berkeley, California + 129 more

Conditions: Poor Quality Sleep
Interventions: Pistachio, Control food; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 45 Years to 64 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer AJCC v7
Interventions: Cryosurgery, Laboratory Biomarker Analysis, Therapeutic Conventional Surgery, Tremelimumab; Procedure · Other · Biological
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma
Interventions: Toca 511, Toca FC, Lomustine, Temozolomide, Bevacizumab; Biological · Drug
Lead sponsor: Tocagen Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 50
States / cities: Phoenix, Arizona • Irvine, California • La Jolla, California + 41 more

Conditions: Type 2 Diabetes
Interventions: DM-CCT, DM-UCT; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Hiv
Interventions: Healthy Choices, Text Message Prompts; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: Tallahassee, Florida • Tampa, Florida • Boston, Massachusetts + 1 more

Conditions: Weight Loss, Obesity
Interventions: Lifestyle counseling; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: HIV/AIDS
Interventions: LINK2 Youth Services Navigation Intervention; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 16 Years to 25 Years · Male only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma
Interventions: Cisplatin, Doxorubicin, Methotrexate, Pegfilgrastim, Pembrolizumab, Radical Cystectomy, Vinblastine Sulfate; Drug · Biological · Procedure
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Metabolic Syndrome
Interventions: Restorative yoga, Stretching; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years to 65 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: San Diego, California • San Francisco, California

Conditions: Cerebral Palsy
Interventions: Prone and Upright Locomotor Training; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 6 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Diabetes
Interventions: Weight loss intervention; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Search by objective public record fields.

Home Biofeedback or Pelvic Floor Physical Therapy for Postpartum Urinary Incontinence.

Pragmatic Clinic-Based Trial of a Mindfulness Based Intervention for Mood Concerns in Youth With Type 1 Diabetes

Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention

Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors

Exercise Training for the Treatment of Generalized Anxiety Disorder

Child Adult Relationship Enhancement in Pediatric Primary Care Parenting Group to Reduce Child Behavior Problems

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

Natural Killer (NK) Cell Transplantation for AML

Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy

Arena Labs - Improving Clinician Well Being

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Impact of Pistachio Consumption on Sleep

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma

Conditional Cash Transfer Intervention to Improve T2DM

SHARE Program: SUSTAIN

Early Intervention for Morbidly Obese Patients After Roux-en-Y Gastric Bypass (RYGB) Surgery

Youth Services Navigation Intervention for HIV+ Youth Being Released From or At-risk for Incarceration

Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Practicing Restorative Yoga or Stretching for the Metabolic Syndrome

Locomotor Learning in Infants at High Risk for Cerebral Palsy

Lifestyle Changes Through Exercise and Nutrition